B. Kasiske

Epidemiology · 2000–2020

A researcher in the Science corpus: 19 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom B. Kasiske trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. H. B. EL‐SERAG

Who trusts B. Kasiske overall

  1. M. Schnitzler
  2. R. Marcén

Papers from B. Kasiske's perspective

Ordered by how strongly the researchers B. Kasiske trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (New England Journal of Medicine)
  2. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
  3. Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
  4. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. (New England Journal of Medicine)
  5. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (Annals of Internal Medicine)
  6. Age affects outcomes in chronic kidney disease. (Journal of the American Society of Nephrology)
  7. Remission of proteinuria improves prognosis in IgA nephropathy. (Journal of the American Society of Nephrology)
  8. The support of human genetic evidence for approved drug indications (Nature Genetics)
  9. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. (Arthritis & Rheumatism)
  10. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)

Their papers